NCT03727139View on ClinicalTrials.gov

"Rasagiline Tablets Special Drug Use-Results Survey Survey on Long-term Safety"

CompletedOBSERVATIONAL
Enrollment

1,021

Participants

Timeline

Start Date

November 1, 2018

Primary Completion Date

October 31, 2021

Study Completion Date

October 31, 2021

Conditions
Parkinson's Disease
Interventions
DRUG

Rasagiline

Rasagiline Tablets

Trial Locations (1)

Unknown

Takeda Selected Site, Tokyo

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY

NCT03727139 - "Rasagiline Tablets Special Drug Use-Results Survey Survey on Long-term Safety" | Biotech Hunter | Biotech Hunter